Ozempic/Wegovy
Ozempic has ‘very rare’ sight loss side effect, EU drugs regulator finds
The EMA’s drug safety committee launched a review of medicines containing semaglutide — the active ingredient in Ozempic, Wegovy and Rybelsus — in January.
June 6, 2025
1:55 pm CET
Longtime US allies say they have ways to fight back against Trump, and they’ll use them
April 23, 2025
4:40 pm CET
Ozempic cut heavy drinking in clinical study
February 12, 2025
7:21 pm CET
Weight-loss drugs can help ‘reverse’ obesity pandemic, say WHO experts
December 18, 2024
5:00 pm CET
Advertisement